Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Finding money to pay off debt can be challenging. Explore creative ways to boost your finances and eliminate debt faster.
22,001 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Data centers are growing fast, driven by cloud and AI. The real engine? Utilities expanding power capacity and reliab...
The crisis now in its third week intensified after a missile strike on the U.S. embassy in Baghdad and a fuel facilit...
Karman Space & Defense reported a solid quarter, but its stock slipped. This article breaks down the factors behind t...
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Rising mortgage rates change buyer behavior and put pressure on single-family demand. This guide explains how mortgag...
Trilogy Metals has fallen hard this week, leaving investors asking whether the downturn is a short-lived pullback or ...
Is chipotle stock long-term buy? This guide breaks down growth engines, risks, and a clear framework to decide if CMG...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
Hometap launches a two-tier pricing model for its home equity investments, offering cheaper costs for early settlemen...
When the market falters, smart investors pivot to high-quality names. This guide outlines five durable stocks to buy ...
NuScale Power's stock action sparks questions about small modular reactors and policy timelines. This guide breaks do...